<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
      <journal-id journal-id-type="pmc">ploscomp</journal-id>
      <journal-title-group>
        <journal-title>PLoS Computational Biology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1553-734X</issn>
      <issn pub-type="epub">1553-7358</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">PCOMPBIOL-D-12-01841</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pcbi.1003004</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Biochemistry</subject>
            <subj-group>
              <subject>Enzymes</subject>
              <subj-group>
                <subject>Enzyme kinetics</subject>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Biophysics</subject>
            <subj-group>
              <subject>Biophysics theory</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Computational biology</subject>
            <subj-group>
              <subject>Systems biology</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Immunology</subject>
            <subj-group>
              <subject>Immune cells</subject>
              <subj-group>
                <subject>T cells</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Immunity</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Mathematics</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Immunology</subject>
          <subject>Computational Biology</subject>
          <subject>Biophysics</subject>
          <subject>Biochemistry</subject>
          <subject>Mathematics</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Systems Model of T Cell Receptor Proximal Signaling Reveals Emergent Ultrasensitivity</article-title>
        <alt-title alt-title-type="running-head">Ultrasensitivity in T Cell Receptors</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Mukhopadhyay</surname>
            <given-names>Himadri</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Cordoba</surname>
            <given-names>Shaun-Paul</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Maini</surname>
            <given-names>Philip K.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>van der Merwe</surname>
            <given-names>P. Anton</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Dushek</surname>
            <given-names>Omer</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <addr-line>Sir William Dunn School of Pathology, University of Oxford, Oxford, Oxfordshire, United Kingdom</addr-line>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <addr-line>Centre for Mathematical Biology, Mathematical Institute, University of Oxford, Oxford, Oxfordshire, United Kingdom</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Haugh</surname>
            <given-names>Jason M.</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">
        <addr-line>North Carolina State University, United States of America</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">anton.vandermerwe@path.ox.ac.uk</email> (PAvdM); <email xlink:type="simple">omer.dushek@path.ox.ac.uk</email> (OD)</corresp>
        <fn fn-type="conflict">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: HM PKM PAvdM OD. Performed the experiments: HM OD. Analyzed the data: HM SPC PKM PAvdM OD. Wrote the paper: HM PKM PAvdM OD.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <month>3</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>3</month>
        <year>2013</year>
      </pub-date>
      <volume>9</volume>
      <issue>3</issue>
      <elocation-id>e1003004</elocation-id>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>11</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>2</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Mukhopadhyay et al</copyright-holder>
        <license xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Receptor phosphorylation is thought to be tightly regulated because phosphorylated receptors initiate signaling cascades leading to cellular activation. The T cell antigen receptor (TCR) on the surface of T cells is phosphorylated by the kinase Lck and dephosphorylated by the phosphatase CD45 on multiple immunoreceptor tyrosine-based activation motifs (ITAMs). Intriguingly, Lck sequentially phosphorylates ITAMs and ZAP-70, a cytosolic kinase, binds to phosphorylated ITAMs with differential affinities. The purpose of multiple ITAMs, their sequential phosphorylation, and the differential ZAP-70 affinities are unknown. Here, we use a systems model to show that this signaling architecture produces emergent ultrasensitivity resulting in switch-like responses at the scale of individual TCRs. Importantly, this switch-like response is an emergent property, so that removal of multiple ITAMs, sequential phosphorylation, or differential affinities abolishes the switch. We propose that highly regulated TCR phosphorylation is achieved by an emergent switch-like response and use the systems model to design novel chimeric antigen receptors for therapy.</p>
      </abstract>
      <abstract abstract-type="summary">
        <title>Author Summary</title>
        <p>Recognition of antigen by the T cell antigen receptor (TCR) is a central event in the initiation of adaptive immune responses and for this reason the TCR has been extensively studied. Multiple studies performed over the past 20 years have revealed intriguing findings that include the observation that the TCR has multiple phosphorylation sites that are sequentially phosphorylated by the kinase Lck and that ZAP-70, a cytosolic kinase, binds to these sites with different affinities. The purpose of multiple sites, their sequential phosphorylation by Lck, and the differential binding affinities of ZAP-70 are unknown. Using a novel mechanistic model that incorporates a high level of molecular detail, we find, unexpectedly, that all factors are critical for producing ultrasensitivity (switch-like response) and therefore this signaling architecture exhibits systems-level emergent ultrasensitivity. We use the model to study existing therapeutic chimeric antigen receptors and in the design of novel ones. The work also has direct implications to the study of many other immune receptors.</p>
      </abstract>
      <funding-group>
        <funding-statement>This work has been supported by the Medical Research Council (MR/J002011/1), E.P. Abraham Research Fund (BVRVBX0), a Doctoral Training Centre Systems Biology studentship (to HM) from the Engineering and Physical Sciences Research Council (EPSRC), and by a Sir Henry Dale Fellowship (to OD) jointly funded by the Wellcome Trust and the Royal Society (098363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
      </funding-group>
      <counts>
        <page-count count="8"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>T cells patrol the body in search of infection and cancer derived antigens <xref ref-type="bibr" rid="pcbi.1003004-SmithGarvin1">[1]</xref>, <xref ref-type="bibr" rid="pcbi.1003004-Restifo1">[2]</xref>. They are activated to respond by interactions between T cell antigen receptors (TCRs) on their surface and antigens, in the form of peptides bound to major histocompatibility complexes (pMHCs), on the surfaces of antigen presenting cells (APCs). When activated, T cells can lyse infected cells, secrete cytokines, and perform other effector functions that collectively allow T cells to initiate and regulate adaptive immune responses <xref ref-type="bibr" rid="pcbi.1003004-SmithGarvin1">[1]</xref>.</p>
      <p>The importance of the TCR in initiating and regulating adaptive immune responses has meant that TCR proximal proteins have been extensively studied. The TCR itself is a multi-subunit receptor that contains subunits for ligand binding (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e001" xlink:type="simple"/></inline-formula> heterodimer) and signal transduction (CD3<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e002" xlink:type="simple"/></inline-formula> and CD3<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e003" xlink:type="simple"/></inline-formula> heterodimers, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e004" xlink:type="simple"/></inline-formula> homodimer). Collectively, the signal transducing subunits contain 20 tyrosine residues distributed on 10 immunoreceptor tyrosine based activation motifs (ITAMs) <xref ref-type="bibr" rid="pcbi.1003004-Love1">[3]</xref>. These ITAMs are phosphorylated by the SRC-family tyrosine kinase Lck and dephosphorylated by the tyrosine phosphatases, such as CD45. Phosphorylated ITAMs serve as docking sites for the tandem SH2 domain-containing cytosolic kinase ZAP-70, which, upon binding, is able to catalyze additional reactions propagating downstream signaling. Despite the small number of molecules involved, their interactions form the basis of a complex regulation network which is poorly understood <xref ref-type="bibr" rid="pcbi.1003004-Guy1">[4]</xref>.</p>
      <p>There are many intriguing aspects of this signaling module <xref ref-type="bibr" rid="pcbi.1003004-Guy1">[4]</xref>. While each CD3 signal transducing subunit contains a single ITAM, the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e005" xlink:type="simple"/></inline-formula>-chain contains three ITAMs <xref ref-type="bibr" rid="pcbi.1003004-Love1">[3]</xref> (<xref ref-type="fig" rid="pcbi-1003004-g001">Fig. 1</xref>). These 3 ITAMs have been shown to be sequentially phosphorylated (membrane-distal to membrane-proximal) by Lck <xref ref-type="bibr" rid="pcbi.1003004-vanOers1">[5]</xref> and it has been shown that ZAP-70 binds to these ITAMs with increasing affinities (membrane-distal to membrane-proximal) <xref ref-type="bibr" rid="pcbi.1003004-Isakov1">[6]</xref>–<xref ref-type="bibr" rid="pcbi.1003004-Ottinger1">[10]</xref>. In addition, CD45, a phosphatase that dephosphorylates these ITAMs, is thought to be among the most abundant molecules on T cells <xref ref-type="bibr" rid="pcbi.1003004-Zamoyska1">[11]</xref>. The purpose of multiple ITAMs, their sequential phosphorylation, the differential binding affinities of ZAP-70, and the abundance of CD45 remain unknown.</p>
      <fig id="pcbi-1003004-g001" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1003004.g001</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Schematic of the T cell receptor proximal signaling molecules considered in the systems model.</title>
          <p>We consider the TCR<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e006" xlink:type="simple"/></inline-formula>-chain containing three ITAMs, labelled as <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e007" xlink:type="simple"/></inline-formula>3 (membrane-distal) to <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e008" xlink:type="simple"/></inline-formula>1 (membrane-proximal). These ITAMs are sequentially phosphorylated by the tyrosine kinase Lck and dephosphorylated by the phosphatase CD45. The cytosolic kinase ZAP-70 contains tandem SH2 domains which are able to bind to doubly (fully) phosphorylated ITAMs with differential affinities, with the smallest affinity to <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e009" xlink:type="simple"/></inline-formula>3 and largest affinity to <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e010" xlink:type="simple"/></inline-formula>1. When bound to phosphorylated ITAMs, ZAP-70 is able to propagate signaling by phosphorylating downstream signaling molecules and adaptors.</p>
        </caption>
        <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003004.g001" position="float" xlink:type="simple"/>
      </fig>
      <p>The binding of pMHC to the TCR is thought to change the kinase-phosphatase ratio leading to phosphorylation of TCR ITAMs and the initiation of an intracellular signaling cascade that leads to T cell activation, which, if inappropriate, can result in autoimmune disorders <xref ref-type="bibr" rid="pcbi.1003004-vanderMerwe1">[12]</xref>. Therefore TCR ITAM phosphorylation is thought to be tightly regulated. Given that Lck and CD45 are constitutively active in resting T cells <xref ref-type="bibr" rid="pcbi.1003004-Secrist1">[13]</xref>, <xref ref-type="bibr" rid="pcbi.1003004-Nika1">[14]</xref>, spontaneous (stochastic) pMHC-independent fluctuations in the local Lck or CD45 concentrations can lead to ITAM phosphorylation. These fluctuations may also allow for ITAM phosphorylation in response to endogenous pMHC. On the other hand, maximal ITAM phosphorylation should proceed for antigenic pMHC. Switch-like responses at the scale of individual TCRs provide thresholds, so that phosphorylation is prevented over a wide range of enzyme concentrations below the threshold, and all-or-none responses, so that maximal ITAM phosphorylation proceeds beyond the threshold. However, it is presently unknown whether the TCR proximal signaling architecture supports a switch-like response at the scale of individual TCRs.</p>
      <p>In recent years, therapies have been developed to exploit T cells by re-directing them towards infected or cancerous cells <xref ref-type="bibr" rid="pcbi.1003004-Restifo1">[2]</xref>. Several research groups have developed therapies based on chimeric antigen receptors (CARs), whereby the variable domains of a monoclonal antibody recognizing pathogen or cancer derived antigens is fused to a signaling chain, most commonly the TCR<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e011" xlink:type="simple"/></inline-formula>-chain <xref ref-type="bibr" rid="pcbi.1003004-Sadelain1">[15]</xref>. These CARs are transfected into T cells that are then adoptively transferred into patients, generating a pathogen/cancer specific T cell population. However, the antigenic targets of CARs, although highly expressed on cancerous cells are not exclusively expressed on these cells. This observation, coupled with the fact that the extracellular domains of CARs often exhibit very high affinity to their target antigens, means that off-target cell killing can be frequent <xref ref-type="bibr" rid="pcbi.1003004-Sadelain1">[15]</xref>. Therefore, optimal CARs should exhibit low potency, so that T cells only respond to cells that highly express target antigens, and CARs should also exhibit a high maximum response to ensure complete target cell killing when responding. Although CARs are routinely modified in order to achieve these desired properties, there is presently no mechanistic model to guide the rational development of the signaling domains of CARs to obtain optimal properties.</p>
      <p>Here, we construct a systems model of TCR proximal signaling that includes the 3 <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e012" xlink:type="simple"/></inline-formula>-chain ITAMs, their sequential phosphorylation by Lck, and the differential binding affinity of ZAP-70 to these ITAMs. We find that this signaling architecture produces a novel mechanism of ultrasensitivity (switch-like response) at the scale of individual TCRs. Interestingly, we find that all three factors are critical for generating a switch-like response, so that removal of ITAMs, sequential phosphorylation, <italic>or</italic> differential ZAP-70 binding affinities abolishes the switch and therefore this switch can be thought of as an emergent property of the TCR proximal signaling architecture. Our results provide a rationale for the intriguing architecture of TCR proximal signaling and provide a mechanistic framework for the design of novel CARs with desired properties.</p>
    </sec>
    <sec id="s2">
      <title>Results</title>
      <sec id="s2a">
        <title>Multiple TCR<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e013" xlink:type="simple"/></inline-formula>-chain ITAMs produce signal amplification, high potency, and ultrasensitivity</title>
        <p>We construct a systems model that incorporates the enzymatic kinetics of the tyrosine kinase Lck in sequentially phosphorylating and the dominant phosphatase CD45 in dephosphorylating the three <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e014" xlink:type="simple"/></inline-formula>-chain ITAMs <xref ref-type="bibr" rid="pcbi.1003004-vanOers1">[5]</xref>. In this way, the third membrane-distal ITAM (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e015" xlink:type="simple"/></inline-formula>3) must be doubly phosphorylated before Lck is able to phosphorylate the second ITAM (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e016" xlink:type="simple"/></inline-formula>2), and so on. The model incorporates ZAP-70 by allowing it to bind each ITAM when it is doubly phosphorylated, independent of reactions taking place by Lck or CD45 on other ITAMs. The affinity between ZAP-70 and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e017" xlink:type="simple"/></inline-formula>1 is taken to be 10-fold higher than <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e018" xlink:type="simple"/></inline-formula>2, which we take to have an affinity 10-fold higher than <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e019" xlink:type="simple"/></inline-formula>3. The exact affinity values for ZAP-70 binding for each ITAM differ between studies <xref ref-type="bibr" rid="pcbi.1003004-Isakov1">[6]</xref>–<xref ref-type="bibr" rid="pcbi.1003004-Ottinger1">[10]</xref> and therefore we vary these parameters. All enzymatic reactions are modelled in full without any simplifications. The system of ordinary-differential-equations (ODEs) is generated in BioNetGen <xref ref-type="bibr" rid="pcbi.1003004-Faeder1">[16]</xref>, a rule-based framework for generating biochemical reaction networks, and produced 53 chemical species and 168 reactions (see <xref ref-type="sec" rid="s4">Methods</xref>). The number of chemical species and reactions is large despite only including 4 distinct molecules because the systems model accurately captures all possible molecular complexes that can form.</p>
        <p>To study how this signaling architecture regulates the activity of ZAP-70, the concentration of ITAM-bound ZAP-70 was calculated as a function of the relative concentration of active Lck and CD45 (<xref ref-type="fig" rid="pcbi-1003004-g002">Fig. 2A</xref>). In the case of the wild-type TCR<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e020" xlink:type="simple"/></inline-formula>-chain (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e021" xlink:type="simple"/></inline-formula>123), we unexpectedly observed an ultrasensitive or switch-like response, whereby small perturbations to Lck or CD45 produced large changes in the concentration of bound ZAP-70. We quantified this observation by fitting a Hill function to the kinase-phosphatase curve to extract estimates of the maximum (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e022" xlink:type="simple"/></inline-formula>, <xref ref-type="fig" rid="pcbi-1003004-g002">Fig. 2B</xref>), the potency (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e023" xlink:type="simple"/></inline-formula>, <xref ref-type="fig" rid="pcbi-1003004-g002">Fig. 2C</xref>), and the sensitivity (Hill number, <xref ref-type="fig" rid="pcbi-1003004-g001">Fig. 1D</xref>). We found a Hill number of 5.2, which is greater than 1, indicating a switch-like response. This ultrasensitivity is unexpected because the concentrations of the modifying enzymes (Lck, CD45) are comparable or in excess of the substrate (TCR<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e024" xlink:type="simple"/></inline-formula>-chain) and therefore the observed ultrasensitivity is not a result of the classic zero-order mechanism <xref ref-type="bibr" rid="pcbi.1003004-Goldbeter1">[17]</xref>.</p>
        <fig id="pcbi-1003004-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1003004.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Multiple <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e025" xlink:type="simple"/></inline-formula>-chain ITAMs not only mediate signal amplification, but also increase potency and sensitivity.</title>
            <p>A) The concentration of ITAM-bound ZAP-70 as a function of the relative kinase (E) to phosphatase (F) concentration. As expected, when the phosphatase is in excess the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e026" xlink:type="simple"/></inline-formula>-chain is dephosphorylated and ZAP-70 cannot bind whereas when the kinase is in excess the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e027" xlink:type="simple"/></inline-formula>-chain is phosphorylated and ZAP-70 is fully bound. <xref ref-type="sec" rid="s2">Results</xref> are shown for the wild-type <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e028" xlink:type="simple"/></inline-formula>-chain (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e029" xlink:type="simple"/></inline-formula>123) and for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e030" xlink:type="simple"/></inline-formula>-chains where the first and second ITAMs are removed, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e031" xlink:type="simple"/></inline-formula>X23 and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e032" xlink:type="simple"/></inline-formula>XX3, respectively. Inset shows normalized curves, highlighting differences in potency (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e033" xlink:type="simple"/></inline-formula>) and sensitivity (Hill number), which is a measure of the curve steepness. Each curve is fit to a Hill function to extract estimates of B) the maximum (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e034" xlink:type="simple"/></inline-formula>), C) the potency (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e035" xlink:type="simple"/></inline-formula>), and D) the sensitivity (Hill number). Model and parameter values can be found in <xref ref-type="sec" rid="s4">Methods</xref>.</p>
          </caption>
          <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003004.g002" position="float" xlink:type="simple"/>
        </fig>
        <p>We next investigated the contribution of multiple ITAMs. We repeated the calculations when removing the first ITAM (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e036" xlink:type="simple"/></inline-formula>X23) or both the first and second ITAMs (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e037" xlink:type="simple"/></inline-formula>XX3) (<xref ref-type="fig" rid="pcbi-1003004-g002">Fig. 2A</xref>). As expected, we observed a reduction in the maximum concentration of bound ZAP-70 (<xref ref-type="fig" rid="pcbi-1003004-g002">Fig. 2B</xref>), reflecting the signal amplification characteristic of multiple ITAMs <xref ref-type="bibr" rid="pcbi.1003004-Irving1">[18]</xref>, <xref ref-type="bibr" rid="pcbi.1003004-Holst1">[19]</xref>. However, removal of ITAMs also decreased potency (<xref ref-type="fig" rid="pcbi-1003004-g002">Fig. 2C</xref>) and sensitivity (<xref ref-type="fig" rid="pcbi-1003004-g002">Fig. 2D</xref>). These effects were not mediated by substrate concentration, as increasing the concentration of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e038" xlink:type="simple"/></inline-formula>XX3 by a factor of 3 did not restore ultrasensitivity or potency (not shown). Therefore multiple ITAMs on a single <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e039" xlink:type="simple"/></inline-formula>-chain are predicted to mediate not only signal amplification, but also potency and sensitivity.</p>
      </sec>
      <sec id="s2b">
        <title>ZAP-70 binding modulates potency and ultrasensitivity</title>
        <p>We next investigated the contribution of ZAP-70 binding to potency and sensitivity. To do this, we calculated the total concentration of phosphorylated <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e040" xlink:type="simple"/></inline-formula>-chain, as may be detected by an anti-phosphotyrosine antibody, as a function of the ratio of active enzymes in, respectively, the absence and presence of ZAP-70 (<xref ref-type="fig" rid="pcbi-1003004-g003">Fig. 3A</xref>, blue and green curves). A marked increase in potency and ultrasensitivity is observed in the presence of ZAP-70 (<xref ref-type="fig" rid="pcbi-1003004-g003">Fig. 3B,C</xref>).</p>
        <fig id="pcbi-1003004-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1003004.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>ZAP-70 binding to phosphorylated ITAMs enhances both ultrasensitivity and potency.</title>
            <p>A) The concentration of total <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e041" xlink:type="simple"/></inline-formula>-chain phosphorylation as a function of the relative concentration of active kinase (E) to phosphatase (F). <xref ref-type="sec" rid="s2">Results</xref> are shown for sequential phosphorylation (blue, green) and random phosphorylation (red, orange) in the absence (blue, red) and presence (green, orange) of ZAP-70. B) Hill numbers and C) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e042" xlink:type="simple"/></inline-formula> for all four curves reveal that ZAP-70 binding dramatically increases both ultrasensitivity and potency when phosphorylation is sequential but not random.</p>
          </caption>
          <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003004.g003" position="float" xlink:type="simple"/>
        </fig>
        <p>The increase in potency (decrease in <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e043" xlink:type="simple"/></inline-formula>) in the presence of ZAP-70 occurs because ITAMs bound by ZAP-70 become inaccessible to phosphatases. Therefore, the absolute ZAP-70 affinity for ITAMs is expected to determine potency. Comparisons between the wild-type <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e044" xlink:type="simple"/></inline-formula>-chain (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e045" xlink:type="simple"/></inline-formula>123) and domain duplication constructs that contain three copies of the high affinity ITAM (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e046" xlink:type="simple"/></inline-formula>111), intermediate affinity ITAM (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e047" xlink:type="simple"/></inline-formula>222), and low affinity ITAM (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e048" xlink:type="simple"/></inline-formula>333) reveal that increased potency can be achieved by increasing the ZAP-70 affinity (<xref ref-type="fig" rid="pcbi-1003004-g004">Fig. 4A–C</xref>). The high potency (low <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e049" xlink:type="simple"/></inline-formula>) observed in the presence of ZAP-70 provides a plausible explanation for the abundance of CD45 on T cells. In order to keep the TCR unphosphorylated, an excess of phosphatase is required to balance the constitutive activity of Lck and the binding of ZAP-70.</p>
        <fig id="pcbi-1003004-g004" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1003004.g004</object-id>
          <label>Figure 4</label>
          <caption>
            <title>The absolute ZAP-70 affinity for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e050" xlink:type="simple"/></inline-formula>-chain ITAMs modulates potency.</title>
            <p>A) The concentration of bound ZAP-70 as a function of the concentration of active kinase (E) to phosphatase (F). <xref ref-type="sec" rid="s2">Results</xref> are shown for the wild-type <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e051" xlink:type="simple"/></inline-formula>-chain (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e052" xlink:type="simple"/></inline-formula>123) and for three additional <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e053" xlink:type="simple"/></inline-formula>-chains that contain all high affinity ITAM 1 (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e054" xlink:type="simple"/></inline-formula>111), intermediate affinity ITAM 2 (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e055" xlink:type="simple"/></inline-formula>222), or low affinity ITAM 3 (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e056" xlink:type="simple"/></inline-formula>333). Comparison of these <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e057" xlink:type="simple"/></inline-formula>-chains reveals that B) sensitivity is unchanged whilst C) potency is modulated.</p>
          </caption>
          <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003004.g004" position="float" xlink:type="simple"/>
        </fig>
        <p>We observed reduced sensitivity for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e058" xlink:type="simple"/></inline-formula>-chains containing identical ITAMs (<xref ref-type="fig" rid="pcbi-1003004-g004">Fig. 4</xref>) and therefore surmised that the differential ZAP-70 affinities produce ultrasensitivity. In <xref ref-type="fig" rid="pcbi-1003004-g005">Fig. 5A</xref> we compare the wild-type <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e059" xlink:type="simple"/></inline-formula>-chain (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e060" xlink:type="simple"/></inline-formula>123) to a construct containing identical ITAMs (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e061" xlink:type="simple"/></inline-formula>222) and to a construct where ITAM 1 and 3 have switched positions (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e062" xlink:type="simple"/></inline-formula>321). We observe that ultrasensitivity relies not only on differential ZAP-70 affinities but also on differential affinities that increase in the direction of phosphorylation (i.e. membrane-distal to membrane-proximal). This is comprehensively illustrated in <xref ref-type="fig" rid="pcbi-1003004-g005">Fig. 5B</xref>, which shows a heat map of Hill numbers as a function of the ZAP-70 unbinding rate for ITAM 1 (x-axis) and ITAM 3 (y-axis) when the unbinding rate for ITAM 2 is fixed at 1 <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e063" xlink:type="simple"/></inline-formula>. Ultrasensitivity is observed when the unbinding rate is small for ITAM 1 and large for ITAM 3.</p>
        <fig id="pcbi-1003004-g005" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1003004.g005</object-id>
          <label>Figure 5</label>
          <caption>
            <title>Differential ZAP-70 affinity and sequential phosphorylation produces ultrasensitivity.</title>
            <p>A) The concentration of bound ZAP-70 as a function of the relative concentration of active kinase (E) to phosphatase (F). Shown are the wild-type <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e064" xlink:type="simple"/></inline-formula>-chain (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e065" xlink:type="simple"/></inline-formula>123), and additional constructs where all ITAMs are identical (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e066" xlink:type="simple"/></inline-formula>222), switched (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e067" xlink:type="simple"/></inline-formula>321), or where phosphorylation is no longer sequential (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e068" xlink:type="simple"/></inline-formula>123 Random). The Hill numbers (inset) reveal that ultrasensitivity is decreased if ZAP-70 does not exhibit differential affinity (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e069" xlink:type="simple"/></inline-formula>222), if the affinity decreases as the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e070" xlink:type="simple"/></inline-formula> is sequentially phosphorylated (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e071" xlink:type="simple"/></inline-formula>321), or if phosphorylation is no longer sequential. B) Heat map of Hill numbers as a function of the ZAP-70 unbinding rate for ITAM 1 (Z<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e072" xlink:type="simple"/></inline-formula>) and ITAM 3 (Z<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e073" xlink:type="simple"/></inline-formula>), where the unbinding rate for ITAM 2 is fixed at 1 s<sup>−1</sup>. The calculation is performed under sequential phosphorylation. Maximum sensitivity is found in the top left of the heat map, where ZAP-70 binds with the largest affinity to ITAM 1 and with lowest affinity to ITAM 3. The heat map is repeated using an alternate measure of sensitivity in <xref ref-type="supplementary-material" rid="pcbi.1003004.s003">Fig. S3</xref>. Note that the heat map colour scheme in panel B is not related to the colour scheme in panel A.</p>
          </caption>
          <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003004.g005" position="float" xlink:type="simple"/>
        </fig>
        <p>The ITAMs located on the TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e074" xlink:type="simple"/></inline-formula>-chain are conserved across species <xref ref-type="bibr" rid="pcbi.1003004-Love1">[3]</xref> yet alignment of the three <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e075" xlink:type="simple"/></inline-formula>-chain ITAMs within a species reveals little homology (<xref ref-type="supplementary-material" rid="pcbi.1003004.s001">Fig. S1</xref>). This observation suggests that differences in ITAM sequence are functionally important. Differential binding affinities between ZAP-70 and the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e076" xlink:type="simple"/></inline-formula>-chain ITAMs require differences in ITAM sequence and we have predicted the functional importance of differential ZAP-70 binding affinities. Given that Lck and CD45 also interact with these ITAMs, it is possible that they do so with differential affinities. Differential affinities between the ITAMs and Lck, CD45, or both Lck and CD45 can produce ultrasensitivity in the absence of ZAP-70 (<xref ref-type="supplementary-material" rid="pcbi.1003004.s002">Fig. S2</xref>).</p>
        <p>In summary, the absolute ZAP-70 affinity for the TCR ITAMs controls potency while the differential ZAP-70 affinity produces ultrasensitivity.</p>
      </sec>
      <sec id="s2c">
        <title>Sequential phosphorylation is required for ultrasensitivity</title>
        <p>The observation that ultrasensitivity relies on ZAP-70 affinities increasing in the direction of sequential phosphorylation (<xref ref-type="fig" rid="pcbi-1003004-g005">Fig. 5A</xref>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e077" xlink:type="simple"/></inline-formula>123 vs <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e078" xlink:type="simple"/></inline-formula>321), suggests that sequential phosphorylation may contribute to ultrasensitivity. We contrasted sequential phosphorylation to random phosphorylation, whereby each ITAM can be independently phosphorylated or dephosphorylated. We found that removal of sequential phosphorylation abolished ultrasensitivity in both total <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e079" xlink:type="simple"/></inline-formula>-chain phosphorylation (<xref ref-type="fig" rid="pcbi-1003004-g003">Fig. 3A</xref>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e080" xlink:type="simple"/></inline-formula>123 Random) and in bound ZAP-70 (<xref ref-type="fig" rid="pcbi-1003004-g005">Fig. 5A</xref>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e081" xlink:type="simple"/></inline-formula>123 Random).</p>
      </sec>
      <sec id="s2d">
        <title>Ultrasensitivity is an emergent property of the TCR proximal signaling architecture, relying on multiple ITAMs, sequential phosphorylation, and differential ZAP-70 affinity</title>
        <p>We have shown the contribution of multiple ITAMs, sequential phosphorylation, and differential ZAP-70 affinity to producing ultrasensitivity. Importantly, ultrasensitivity critically relies on each of these factors so that removal of multiple ITAMs (<xref ref-type="fig" rid="pcbi-1003004-g002">Fig. 2A</xref>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e082" xlink:type="simple"/></inline-formula>XX3), removal of sequential phosphorylation (<xref ref-type="fig" rid="pcbi-1003004-g005">Fig. 5A</xref>, Random <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e083" xlink:type="simple"/></inline-formula>123), <italic>or</italic> differential ZAP-70 affinity (<xref ref-type="fig" rid="pcbi-1003004-g005">Fig. 5B</xref>) can markedly reduce or abolish ultrasensitivity. We therefore conclude that ultrasensitivity is an emergent property of the TCR proximal signaling architecture.</p>
        <p>The origin of the proposed emergent ultrasensitivity is in the effective cooperative binding of the ZAP-70 and it can be compared to classical ultrasensitivity observed in allosteric models of Haemoglobin <xref ref-type="bibr" rid="pcbi.1003004-Monod1">[20]</xref>. In these models, as the total ligand concentration increases the concentration of bound ligand exhibits an ultrasensitive response (with large Hill numbers) because ligand binding induces an allosteric conformational change in the receptor that increases the effective binding affinity of subsequent ligand binding. Similarly, increasing the concentration of Lck increases the phosphorylation of the TCR which sequentially produces docking sites for ZAP-70 of increasing affinity. In both cases if the affinity does not increase as molecules bind to the receptor ultrasensitivity is lost. In the case of the TCR, increases in affinity critically rely on the binding sites being sequentially phosphorylated and ZAP-70 having different affinities for these sites, implicitly implying a requirement for multiple ITAMs.</p>
      </sec>
      <sec id="s2e">
        <title>Design of novel chimeric antigen receptors</title>
        <p>As described in the <xref ref-type="sec" rid="s1">Introduction</xref>, chimeric antigen receptors (CARs) are routinely developed without predictive mechanistic models of signaling. We therefore applied the present mechanistic model to understand existing CARs and to design novel CARs. The growing consensus in the community is that optimal CARs should exhibit high affinity to target antigens, low antigen potency, and large maximum responses (see <xref ref-type="sec" rid="s1">Introduction</xref>). Early studies compared CARs containing the TCR<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e084" xlink:type="simple"/></inline-formula>-chain and the FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e085" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e086" xlink:type="simple"/></inline-formula>-chain <xref ref-type="bibr" rid="pcbi.1003004-Roberts1">[21]</xref>, <xref ref-type="bibr" rid="pcbi.1003004-Haynes1">[22]</xref>. These studies showed improved cytotoxic responses from <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e087" xlink:type="simple"/></inline-formula>-chain fused CARs compared to FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e088" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e089" xlink:type="simple"/></inline-formula>-chain fused CARs. The key differences between these two signaling chains are ITAM multiplicity and ZAP-70 affinity; whereas the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e090" xlink:type="simple"/></inline-formula>-chain contains 3 ITAMs that bind ZAP-70 with various affinities, the FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e091" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e092" xlink:type="simple"/></inline-formula>-chain contains only a single low affinity ITAM. The FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e093" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e094" xlink:type="simple"/></inline-formula> ITAM has an affinity comparable to the low-affinity <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e095" xlink:type="simple"/></inline-formula>3 ITAM <xref ref-type="bibr" rid="pcbi.1003004-Ottinger1">[10]</xref>.</p>
        <p>In <xref ref-type="fig" rid="pcbi-1003004-g006">Fig. 6</xref> we compare six different CAR designs. CARs containing a single ITAM taken from <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e096" xlink:type="simple"/></inline-formula>1, FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e097" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e098" xlink:type="simple"/></inline-formula>, and FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e099" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e100" xlink:type="simple"/></inline-formula> exhibit successively lower ZAP-70 affinity, with 10-fold decreased affinity between <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e101" xlink:type="simple"/></inline-formula>1 and FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e102" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e103" xlink:type="simple"/></inline-formula> and a further 10-fold decrease in affinity between FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e104" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e105" xlink:type="simple"/></inline-formula> and FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e106" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e107" xlink:type="simple"/></inline-formula> <xref ref-type="bibr" rid="pcbi.1003004-Ottinger1">[10]</xref>. Using these ITAMs, we construct single or triple ITAM CARs and find that low potency and maximum responses are best achieved by a triple low affinity ITAM signaling chain based on the ITAM from FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e108" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e109" xlink:type="simple"/></inline-formula>.</p>
        <fig id="pcbi-1003004-g006" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1003004.g006</object-id>
          <label>Figure 6</label>
          <caption>
            <title>The mathematical model predicts novel chimeric antigen receptors (CARs) design.</title>
            <p>A) The concentration of bound ZAP-70 as a function of the relative concentration of active kinase (E) to phosphatase (F) for six cytoplasmic CAR domains. These domains include the wild-type <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e110" xlink:type="simple"/></inline-formula>-chain (blue), chains containing 3 copies of the low affinity ITAM from FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e111" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e112" xlink:type="simple"/></inline-formula> (green) and FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e113" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e114" xlink:type="simple"/></inline-formula> (red), a single high affinity <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e115" xlink:type="simple"/></inline-formula>-chain ITAM (orange), and chains containing a single copy of the low affinity ITAM from FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e116" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e117" xlink:type="simple"/></inline-formula> (magenta) and FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e118" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e119" xlink:type="simple"/></inline-formula> (grey). B-C) Illustrates the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e120" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e121" xlink:type="simple"/></inline-formula> for all CARs shown in panel A. Most CARs are developed based on the wild-type <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e122" xlink:type="simple"/></inline-formula>-chain but this construct, although having a large <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e123" xlink:type="simple"/></inline-formula> has an undesirably large potency (low <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e124" xlink:type="simple"/></inline-formula>). Novel CARs containing multiple low affinity ITAMs (e.g. (FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e125" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e126" xlink:type="simple"/></inline-formula>)x3, (FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e127" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e128" xlink:type="simple"/></inline-formula>)x3) have the desirably low potency (large <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e129" xlink:type="simple"/></inline-formula>) while maintaining the desirably large <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e130" xlink:type="simple"/></inline-formula>.</p>
          </caption>
          <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003004.g006" position="float" xlink:type="simple"/>
        </fig>
        <p>In summary, although the commonly used TCR<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e131" xlink:type="simple"/></inline-formula>-chain exhibits a larger maximum compared to the single ITAM-containing FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e132" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e133" xlink:type="simple"/></inline-formula>, it has an undesirably large potency (small <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e134" xlink:type="simple"/></inline-formula>). We predict that improved CARs, with reduced off-target cell killing, can be generated by using three (or more) low affinity ITAMs, such as the FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e135" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e136" xlink:type="simple"/></inline-formula> or FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e137" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e138" xlink:type="simple"/></inline-formula> ITAM. Experimental assays to evaluate these novel CARs are discussed below.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Discussion</title>
      <p>We have used a systems model to reveal that multiple ITAMs, sequential phosphorylation, and differential ZAP-70 binding produces emergent switch-like responses at the scale of individual TCRs. This provides a rationale for understanding the functional significance of these previously described aspects of the TCR proximal signaling architecture.</p>
      <sec id="s3a">
        <title>Differential binding affinity</title>
        <p>Evidence for differential ZAP-70 binding affinities comes from competition experiments performed at low temperatures with the SH2 domains of ZAP-70 <xref ref-type="bibr" rid="pcbi.1003004-Isakov1">[6]</xref>–<xref ref-type="bibr" rid="pcbi.1003004-Vly1">[9]</xref>, <xref ref-type="bibr" rid="pcbi.1003004-Osman1">[23]</xref>. Future work is required to directly measure the affinity of full ZAP-70 at 37°C. Given that switch-like responses can be produced by differential binding of Lck, CD45, or both, (see <xref ref-type="supplementary-material" rid="pcbi.1003004.s002">Fig. S2</xref>) it will be interesting to experimentally measure the enzymatic activities of Lck and CD45 with respect to each <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e139" xlink:type="simple"/></inline-formula>-chain ITAM.</p>
      </sec>
      <sec id="s3b">
        <title>Sequential phosphorylation</title>
        <p>We have assumed that phosphorylation of the TCR<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e140" xlink:type="simple"/></inline-formula>-chain proceeds sequentially from the membrane-distal to the membrane-proximal ITAM <xref ref-type="bibr" rid="pcbi.1003004-vanOers1">[5]</xref>. However, earlier work suggested an alternate and more complex sequence of phosphorylation whereby individual tyrosines across ITAMs are phosphorylated first, possibly before any individual ITAM is fully phosphorylated <xref ref-type="bibr" rid="pcbi.1003004-Kersh1">[24]</xref>. This alternate sequence is compatible with our model provided that fully phosphorylated ITAMs appear in sequence from membrane-distal to membrane-proximal. The mechanism underlying sequential phosphorylation of the TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e141" xlink:type="simple"/></inline-formula>-chain is unknown <xref ref-type="bibr" rid="pcbi.1003004-Guy1">[4]</xref>. Recently, it has been proposed that lipid-binding segments of the cytoplasmic domain of PECAM-1 mediate sequential tyrosine phosphorylation <xref ref-type="bibr" rid="pcbi.1003004-Paddock1">[25]</xref>. Given that lipid-binding basic residue rich stretch (BRS) are present in the TCR signaling subunits and have been shown to associate with the plasma membrane <xref ref-type="bibr" rid="pcbi.1003004-Xu1">[26]</xref>–<xref ref-type="bibr" rid="pcbi.1003004-Zhang1">[28]</xref>, it may be that their interactions mediate sequential phosphorylation.</p>
      </sec>
      <sec id="s3c">
        <title>Significance of high levels of phosphatase</title>
        <p>Our detailed model has revealed that an excess of CD45 over Lck is required to keep the TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e142" xlink:type="simple"/></inline-formula>-chain dephosphorylated because although Lck and CD45 may have similar enzymatic rates, the binding of the ZAP-70 SH2 domains to phosphorylated ITAMs protects them from dephosphorylation. Previous work has demonstrated that SH2 domains protect tyrosines from dephosphorylatoin by phosphatases <xref ref-type="bibr" rid="pcbi.1003004-Rotin1">[29]</xref>. This asymmetry in signaling, whereby molecules bind and protect phosphorylated but not dephosphorylated tyrosines, may apply to other ITAM, ITIM, and ITSM mediated signaling and may explain the need for abundant phosphatases on immune cells. Mathematical models have previously highlighted the need for high phosphatase activity in order to explain the rapid dephosphorylation of tyrosine phosphorylated receptors <xref ref-type="bibr" rid="pcbi.1003004-Faeder2">[30]</xref>, <xref ref-type="bibr" rid="pcbi.1003004-Kleiman1">[31]</xref>.</p>
      </sec>
      <sec id="s3d">
        <title>Relation to existing mathematical models</title>
        <p>We have studied the regulation of the TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e143" xlink:type="simple"/></inline-formula>-chain using a systems model that includes Lck, CD45, the TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e144" xlink:type="simple"/></inline-formula>-chain, and ZAP-70. Despite including only four molecules, the interaction network that we have generated is very large because of the combinatorial complexity that emerges from including a high level of molecular detail. Previous studies have included these molecules and many others <xref ref-type="bibr" rid="pcbi.1003004-AltanBonnet1">[32]</xref>, <xref ref-type="bibr" rid="pcbi.1003004-Das1">[33]</xref> but at the cost of removing molecular detail.</p>
        <p>The activity of Lck has been proposed to be regulated by CD45 and several other molecules. A previous mathematical model has predicted that this regulation may produce bistability in the activity of Lck <xref ref-type="bibr" rid="pcbi.1003004-Fuss1">[34]</xref> but, to our knowledge, bistability in Lck has not been experimentally observed. Moreover, experimental work has shown that the concentration of Lck in its various phosphorylation states remains largely unchanged upon T cell activation <xref ref-type="bibr" rid="pcbi.1003004-Nika1">[14]</xref>. We have omitted this in the present work because it would dramatically increase the complexity and uncertainty of the model but expect to extend the model as additional information becomes available. We note that the precise mechanism by which antigen binding to the T cell receptor alters the kinase-phosphatase balance leading to receptor phosphorylation, a process termed receptor triggering, remains controversial <xref ref-type="bibr" rid="pcbi.1003004-vanderMerwe1">[12]</xref>. A complete understanding of receptor triggering will provide insights into how antigens of varying affinity alter TCR proximal signaling <xref ref-type="bibr" rid="pcbi.1003004-SmithGarvin1">[1]</xref>, <xref ref-type="bibr" rid="pcbi.1003004-Dushek1">[35]</xref>, <xref ref-type="bibr" rid="pcbi.1003004-Dushek2">[36]</xref>.</p>
        <p>The TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e145" xlink:type="simple"/></inline-formula>-chain contains 6 phosphorylation sites and is therefore considered a multisite substrate. There is a growing body of literature investigating the purpose of multisite phosphorylation <xref ref-type="bibr" rid="pcbi.1003004-Salazar1">[37]</xref>. Previously, it was proposed that membrane-anchored, but not cytosolic, multisite substrates can produce ultrasensitivity <xref ref-type="bibr" rid="pcbi.1003004-Dushek3">[38]</xref>. However, to achieve Hill numbers of greater than 5 membrane-anchored substrates require <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e146" xlink:type="simple"/></inline-formula> phosphorylation sites whereas the TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e147" xlink:type="simple"/></inline-formula>-chain is predicted to achieve this cooperativity with only 6 sites. This level of cooperativity is achieved by both ZAP-70 binding and sequential phosphorylation. The binding of ZAP-70 is a form of product inhibition, which has previously been proposed to increase cooperativity <xref ref-type="bibr" rid="pcbi.1003004-Thomson1">[39]</xref>, <xref ref-type="bibr" rid="pcbi.1003004-Liu1">[40]</xref> and sequential phosphorylation has also been implicated in switch-like responses <xref ref-type="bibr" rid="pcbi.1003004-Wang1">[41]</xref>. Although multiple mechanisms of ultrasensitivity have been previously proposed, the TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e148" xlink:type="simple"/></inline-formula>-chain utilizes mechanisms that cooperate so that large ultrasensitivity is achieved with only 6 phosphorylation sites. We note that the ultrasensitivity we have reported is distinct from multi-stability, which has been previously proposed to be taking place on multisite substrates <xref ref-type="bibr" rid="pcbi.1003004-Thomson1">[39]</xref>, <xref ref-type="bibr" rid="pcbi.1003004-Markevich1">[42]</xref>.</p>
      </sec>
      <sec id="s3e">
        <title>Implications for other receptors</title>
        <p>In addition to the TCR, other immune receptors (e.g. Fc<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e149" xlink:type="simple"/></inline-formula>RIII, IGSF4 <xref ref-type="bibr" rid="pcbi.1003004-Kim1">[43]</xref>, NKp30, NKp46) associate with the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e150" xlink:type="simple"/></inline-formula>-chain and therefore the predictions made here may be applicable to these receptors. There are many other receptors, termed Non-catalytic Tyrosine-Phosphorylated Receptors (NTRs) <xref ref-type="bibr" rid="pcbi.1003004-Dushek4">[44]</xref>, with multiple phosphorylation sites that are regulated by extrinsic enzymes and like the TCR, spurious activation of these receptors may be avoided by switch-like responses that contain strong thresholds. The mathematical model used in the present study can be used to study the regulation of NTR phosphorylation.</p>
      </sec>
      <sec id="s3f">
        <title>Implications for CARs</title>
        <p>CARs are a class of therapeutic receptors that contain variable domains of a monoclonal antibody that recognizes pathogen or cancer derived antigens fused to the TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e151" xlink:type="simple"/></inline-formula>-chain <xref ref-type="bibr" rid="pcbi.1003004-Restifo1">[2]</xref>, <xref ref-type="bibr" rid="pcbi.1003004-Sadelain1">[15]</xref>. The majority of CARs rely on the TCR<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e152" xlink:type="simple"/></inline-formula>-chain, or variants thereof, because early studies showed that CARs containing the TCR<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e153" xlink:type="simple"/></inline-formula>-chain exhibited higher target cell killing efficiencies compared to other signaling chains, such as the FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e154" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e155" xlink:type="simple"/></inline-formula> <xref ref-type="bibr" rid="pcbi.1003004-Haynes1">[22]</xref>. In contrast to the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e156" xlink:type="simple"/></inline-formula>-chain, the FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e157" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e158" xlink:type="simple"/></inline-formula> contains only a single ITAM that binds ZAP-70 with low affinity, comparable to the low affinity interaction between ZAP-70 and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e159" xlink:type="simple"/></inline-formula>3 <xref ref-type="bibr" rid="pcbi.1003004-Ottinger1">[10]</xref>. This improved killing efficiency is likely due to ITAM multiplicity on the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e160" xlink:type="simple"/></inline-formula>-chain (<xref ref-type="fig" rid="pcbi-1003004-g005">Fig. 5</xref>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e161" xlink:type="simple"/></inline-formula>123 vs. FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e162" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e163" xlink:type="simple"/></inline-formula>). However, the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e164" xlink:type="simple"/></inline-formula>-chain containing CAR also has the unfavourable property of increased potency. As shown in <xref ref-type="fig" rid="pcbi-1003004-g005">Fig. 5</xref>, novel CAR designs that maintain low potency and high maximum are possible by using three copies of low affinity ITAMs taken from either FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e165" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e166" xlink:type="simple"/></inline-formula> or FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e167" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e168" xlink:type="simple"/></inline-formula>.</p>
        <p>We propose that <italic>in vitro</italic> target cell killing assays can be used to determine optimal CARs. However, these assays need to be performed using titration of antigens on the target cells (with a fixed number of target cells) not the more commonly performed assay that involves titrating the number of target cells (with a fixed antigen concentration). Optimal CARs should exhibit low potency (large <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e169" xlink:type="simple"/></inline-formula>), only killing cells that highly express specific antigens, and large maximum (large <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e170" xlink:type="simple"/></inline-formula>), killing many cells that highly express specific antigens. An alternative assay is to use measures of cellular activation (e.g. expression of CD107a) in response to titrations of immobilized antigen. In the present work we predict that CARs fused to wild-type <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e171" xlink:type="simple"/></inline-formula>-chain or signaling chains that contain three copies of low affinity ITAMs, such as the FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e172" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e173" xlink:type="simple"/></inline-formula> or FC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e174" xlink:type="simple"/></inline-formula>RI-<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e175" xlink:type="simple"/></inline-formula> ITAMs, will exhibit similar maxima. However, only the signaling chains containing three copies of the low affinity ITAMs will exhibit the desired low potency (large <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e176" xlink:type="simple"/></inline-formula>).</p>
      </sec>
    </sec>
    <sec id="s4" sec-type="methods">
      <title>Methods</title>
      <sec id="s4a">
        <title>Systems model</title>
        <p>The model includes the TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e177" xlink:type="simple"/></inline-formula>-chain with 6 phosphorylation sites (distributed on 3 ITAMs) that are sequentially phosphorylated by Lck (membrane-distal to membrane-proximal) and sequentially dephosphorylated by CD45. We assume that Lck and CD45 cannot simultaneously bind the TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e178" xlink:type="simple"/></inline-formula>-chain. We take <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e179" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e180" xlink:type="simple"/></inline-formula>, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e181" xlink:type="simple"/></inline-formula> to be identical for both enzymes in the main text but discuss alterations in these parameters in <xref ref-type="supplementary-material" rid="pcbi.1003004.s002">Fig. S2</xref>. Doubly phosphorylated ITAMs serve as binding sites for ZAP-70 (provided that CD45 is not bound to the ITAM) and therefore a maximum of three ZAP-70 can bind per TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e182" xlink:type="simple"/></inline-formula>-chain. Binding of ZAP-70 to an ITAM occurs independently of reactions on other ITAMs and while bound, ZAP-70 protects the ITAM from dephosphorylation by CD45 <xref ref-type="bibr" rid="pcbi.1003004-Rotin1">[29]</xref>. Note that ZAP-70 binding only relies on doubly phosphorylated ITAMs and binding is not restricted to any particular sequence. Differential ZAP-70 affinity is implemented by decreasing the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e183" xlink:type="simple"/></inline-formula> for ITAM binding by a factor of 10 between each ITAM (membrane-distal to membrane-proximal) while keeping <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e184" xlink:type="simple"/></inline-formula> identical between ITAMs. Alterations in <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e185" xlink:type="simple"/></inline-formula> between ITAMs can be found in <xref ref-type="fig" rid="pcbi-1003004-g005">Fig. 5B</xref>.</p>
        <p>The system of ODEs representing the biochemical reaction network based on the above scheme was generated in BioNetGen <xref ref-type="bibr" rid="pcbi.1003004-Faeder1">[16]</xref> (see <xref ref-type="bibr" rid="pcbi.1003004-Dushek3">[38]</xref>, <xref ref-type="bibr" rid="pcbi.1003004-Barua1">[45]</xref>–<xref ref-type="bibr" rid="pcbi.1003004-Nag1">[47]</xref> for additional examples of the application of BioNetGen to model reaction networks) and integrated in Matlab (Mathworks, MA). The BioNetGen file used to generate this network is available in <xref ref-type="supplementary-material" rid="pcbi.1003004.s004">Text S1</xref> and contains the set of default parameters (10 reaction rates and 4 chemical concentrations). The parameter values used for concentrations and reaction rates are estimated based on known values. However, we stress that our main results are not sensitive to the precise values of the parameters. The concentration of ITAM-bound ZAP-70 or total <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e186" xlink:type="simple"/></inline-formula>-chain phosphorylation was calculated at steady-state by varying the concentration of phosphatase (identical results can be obtained by varying the concentration of the kinase). Total <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e187" xlink:type="simple"/></inline-formula>-chain phosphorylation is the multiplicative product of 1) the concentration of a particular TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e188" xlink:type="simple"/></inline-formula> isoform (regardless of whether it is bound to an enzyme) and 2) the number of phosphate groups attached to the isoform.</p>
        <p>In addition to the wild-type signaling architecture, several modified architectures were investigated. We compared sequential to random phosphorylation by allowing Lck and CD45 to catalyze reactions at ITAMs independent of the phosphorylation state of the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e189" xlink:type="simple"/></inline-formula>-chain. This random or unstructured phosphorylation scheme generated 2688 reactions and over 500 chemical species compared to 168 reactions and 53 chemical species generated for the sequential scheme. Note that a mixed scheme, whereby phosphorylation is sequential but dephosphorylation is random cannot be implemented without an excessive number of additional assumptions (e.g. if dephosphorylation takes place on ITAM 3 whilst ITAM 2 is fully phosphorylated, is is unclear if sequential phosphorylation requires re-phosphorylation of ITAM 3 before phosphorylation on ITAM 1 can take place). The various <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e190" xlink:type="simple"/></inline-formula>-chain constructs were implemented by changing <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e191" xlink:type="simple"/></inline-formula> between ZAP-70 and each ITAM. For example, the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e192" xlink:type="simple"/></inline-formula>222 construct is generated by taking <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e193" xlink:type="simple"/></inline-formula> s<sup>−1</sup> between ZAP-70 and all 3 ITAMs. In each modified architecture, we preserve all remaining properties of the wild type architecture.</p>
      </sec>
      <sec id="s4b">
        <title>Curve fitting</title>
        <p>The profiles of ITAM-bound ZAP-70 and total TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e194" xlink:type="simple"/></inline-formula>-chain phosphorylation are fit to logarithmic Hill Functions using <italic>lsqcurvefit</italic> in Matlab (Mathworks, MA),<disp-formula id="pcbi.1003004.e195"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003004.e195" xlink:type="simple"/></disp-formula>where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e196" xlink:type="simple"/></inline-formula> corresponds to either ITAM-bound ZAP-70 or total TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e197" xlink:type="simple"/></inline-formula>-chain phosphorylation and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e198" xlink:type="simple"/></inline-formula> the kinase-to-phosphatase ratio on a logarithmic (base 10) scale. The fitted parameter values include: <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e199" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e200" xlink:type="simple"/></inline-formula>, which correspond to the minimum and maximum values, respectively, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e201" xlink:type="simple"/></inline-formula>, which is the logarithmic value of the kinase-to-phosphatase ratio that yields half of the maximal response (otherwise known as potency), and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e202" xlink:type="simple"/></inline-formula>, which is the Hill number that determines the steepness of the response (otherwise known as the sensitivity).</p>
      </sec>
    </sec>
    <sec id="s5">
      <title>Supporting Information</title>
      <supplementary-material id="pcbi.1003004.s001" mimetype="application/postscript" xlink:href="info:doi/10.1371/journal.pcbi.1003004.s001" position="float" xlink:type="simple">
        <label>Figure S1</label>
        <caption>
          <p>Alignment of the TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e203" xlink:type="simple"/></inline-formula>-chain. A) An alignment of the full <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e204" xlink:type="simple"/></inline-formula>-chain across multiple species reveals a high degree of conservation of all three ITAMs. B) An alignment of the three <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e205" xlink:type="simple"/></inline-formula>-chain ITAMs in humans reveals that with the exception of the defining features of the ITAM motif itself, there is very little sequence homology between the three ITAMs. Given the conservation across species, this suggests a functional role for differences between <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e206" xlink:type="simple"/></inline-formula>-chain ITAMs within a species.</p>
          <p>(EPS)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1003004.s002" mimetype="application/postscript" xlink:href="info:doi/10.1371/journal.pcbi.1003004.s002" position="float" xlink:type="simple">
        <label>Figure S2</label>
        <caption>
          <p>Ultrasensitivity in the absence of ZAP-70 can be mediated by differential affinities of Lck, CD45, or both. A) The total phosphorylation of TCR <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e207" xlink:type="simple"/></inline-formula>-chain is shown as a function of the concentration of active Lck to CD45 in the absence of ZAP-70. When both Lck and CD45 have identical ITAM affinities or put another way, when there are no differential affinities, we observe a small Hill number (none, orange curve). Ultrasensitivity is improved if Lck, CD45, or both have differential ITAM affinities (red, green, blue curves, respectively). As for ZAP-70, the differential affinity is achieved by keeping the on-rate identical but varying the off-rate by 10-fold between each ITAM. The catalytic rate is identical between each ITAM. B) Hill numbers for each case in panel A. Note that the increased ultrasensitivity relies on the Lck affinity to increase from membrane-distal to membrane-proximal ITAM while the CD45 affinity must increase from membrane-proximal to membrane-distal, which we have assumed to be the case.</p>
          <p>(EPS)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1003004.s003" mimetype="application/postscript" xlink:href="info:doi/10.1371/journal.pcbi.1003004.s003" position="float" xlink:type="simple">
        <label>Figure S3</label>
        <caption>
          <p>An alternate measure of sensitivity for the heat map in <xref ref-type="fig" rid="pcbi-1003004-g005">Fig. 5B</xref>. We repeat the calculations in <xref ref-type="fig" rid="pcbi-1003004-g005">Fig. 5B</xref> except display the ratio of EC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e208" xlink:type="simple"/></inline-formula> to EC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e209" xlink:type="simple"/></inline-formula> on a log-scale (i.e. log<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e210" xlink:type="simple"/></inline-formula>(EC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e211" xlink:type="simple"/></inline-formula>/EC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003004.e212" xlink:type="simple"/></inline-formula>)) instead of the Hill numbers. We find identical trends and can therefore conclude that the Hill number is a reasonable measure of sensitivity.</p>
          <p>(EPS)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1003004.s004" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003004.s004" position="float" xlink:type="simple">
        <label>Text S1</label>
        <caption>
          <p>BioNetGen source code used to generate the wild-type systems model of T cell receptor proximal signaling.</p>
          <p>(PDF)</p>
        </caption>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank David Gilham, Stephen Cobbold, John Bridgeman, and Vahid Shahrezaei for critically reading the manuscript and providing feedback.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pcbi.1003004-SmithGarvin1">
        <label>1</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smith-Garvin</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Koretzky</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Jordan</surname><given-names>MS</given-names></name> (<year>2009</year>) <article-title>T cell activation</article-title>. <source>Annu Rev Immunol</source> <volume>27</volume>: <fpage>591</fpage>–<lpage>619</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Restifo1">
        <label>2</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Restifo</surname><given-names>NP</given-names></name>, <name name-style="western"><surname>Dudley</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Rosenberg</surname><given-names>SA</given-names></name> (<year>2012</year>) <article-title>Adoptive immunotherapy for cancer: harnessing the T cell response</article-title>. <source>Nat Rev Immunol</source> <volume>12</volume>: <fpage>269</fpage>–<lpage>281</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Love1">
        <label>3</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Love</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Hayes</surname><given-names>SM</given-names></name> (<year>2010</year>) <article-title>ITAM-mediated signaling by the T-cell antigen receptor</article-title>. <source>Cold Spring Harb Perspect Biol</source> <volume>2</volume>: <fpage>a002485</fpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Guy1">
        <label>4</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guy</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Vignali</surname><given-names>DAA</given-names></name> (<year>2009</year>) <article-title>Organization of proximal signal initiation at the TCR:CD3 complex</article-title>. <source>Immunol Rev</source> <volume>232</volume>: <fpage>7</fpage>–<lpage>21</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-vanOers1">
        <label>5</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van Oers</surname><given-names>NS</given-names></name>, <name name-style="western"><surname>Tohlen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Malissen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Moomaw</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Afendis</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>The 21- and 23-kD forms of TCR zeta are generated by specific ITAM phosphorylations</article-title>. <source>Nat Immunol</source> <volume>1</volume>: <fpage>322</fpage>–<lpage>328</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Isakov1">
        <label>6</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Isakov</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wange</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Burgess</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Watts</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Aebersold</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>1995</year>) <article-title>ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity</article-title>. <source>J Exp Med</source> <volume>181</volume>: <fpage>375</fpage>–<lpage>380</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Bu1">
        <label>7</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bu</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Shaw</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>AC</given-names></name> (<year>1995</year>) <article-title>Analysis of the interaction of ZAP-70 and syk protein-tyrosine kinases with the T-cell antigen receptor by plasmon resonance</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>92</volume>: <fpage>5106</fpage>–<lpage>5110</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Zenner1">
        <label>8</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zenner</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Vorherr</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mustelin</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Burn</surname><given-names>P</given-names></name> (<year>1996</year>) <article-title>Differential and multiple binding of signal transducing molecules to the ITAMs of the TCR-zeta chain</article-title>. <source>J Cell Biochem</source> <volume>63</volume>: <fpage>94</fpage>–<lpage>103</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Vly1">
        <label>9</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vly</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Nuns</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Malissen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hedgecock</surname><given-names>CJ</given-names></name> (<year>1997</year>) <article-title>Analysis of immunoreceptor tyrosine-based activation motif (ITAM) binding to ZAP-70 by surface plasmon resonance</article-title>. <source>Eur J Immunol</source> <volume>27</volume>: <fpage>3010</fpage>–<lpage>3014</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Ottinger1">
        <label>10</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ottinger</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Botfield</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Shoelson</surname><given-names>SE</given-names></name> (<year>1998</year>) <article-title>Tandem SH2 domains confer high specificity in tyrosine kinase signaling</article-title>. <source>J Biol Chem</source> <volume>273</volume>: <fpage>729</fpage>–<lpage>735</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Zamoyska1">
        <label>11</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zamoyska</surname><given-names>R</given-names></name> (<year>2007</year>) <article-title>Why is there so much CD45 on T cells?</article-title> <source>Immunity</source> <volume>27</volume>: <fpage>421423</fpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-vanderMerwe1">
        <label>12</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van der Merwe</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Dushek</surname><given-names>O</given-names></name> (<year>2011</year>) <article-title>Mechanisms for T cell receptor triggering</article-title>. <source>Nat Rev Immunol</source> <volume>11</volume>: <fpage>47</fpage>–<lpage>55</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Secrist1">
        <label>13</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Secrist</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Burns</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Karnitz</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Koretzky</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Abraham</surname><given-names>RT</given-names></name> (<year>1993</year>) <article-title>Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events</article-title>. <source>J Biol Chem</source> <volume>268</volume>: <fpage>5886</fpage>–<lpage>5893</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Nika1">
        <label>14</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nika</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Soldani</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Salek</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Paster</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Gray</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Constitutively active Lck kinase in T cells drives antigen receptor signal transduction</article-title>. <source>Immunity</source> <volume>32</volume>: <fpage>766</fpage>–<lpage>777</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Sadelain1">
        <label>15</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sadelain</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Brentjens</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Rivire</surname><given-names>I</given-names></name> (<year>2009</year>) <article-title>The promise and potential pitfalls of chimeric antigen receptors</article-title>. <source>Curr Opin Immunol</source> <volume>21</volume>: <fpage>215</fpage>–<lpage>223</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Faeder1">
        <label>16</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Faeder</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Blinov</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Hlavacekc</surname><given-names>WS</given-names></name> (<year>2009</year>) <article-title>Rule-Based Modeling of Biochemical Systems with BioNetGen</article-title>. <source>Methods in Molecular Biology</source> <volume>500</volume>: <fpage>113</fpage>–<lpage>67</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Goldbeter1">
        <label>17</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goldbeter</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Koshland</surname><given-names>DE</given-names></name> (<year>1981</year>) <article-title>An amplified sensitivity arising from covalent modification in biological systems</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>78</volume>: <fpage>6840</fpage>–<lpage>6844</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Irving1">
        <label>18</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Irving</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>A</given-names></name> (<year>1993</year>) <article-title>Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain</article-title>. <source>J Exp Med</source> <volume>177</volume>: <fpage>1093</fpage>–<lpage>1103</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Holst1">
        <label>19</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Holst</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Eder</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Workman</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Boyd</surname><given-names>KL</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevents autoimmunity</article-title>. <source>Nat Immunol</source> <volume>9</volume>: <fpage>658</fpage>–<lpage>666</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Monod1">
        <label>20</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Monod</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wymand</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Changeux</surname><given-names>JP</given-names></name> (<year>1965</year>) <article-title>On the nature of allosteric transitions: A plausible model</article-title>. <source>J Mol Biol</source> <volume>12</volume>: <fpage>88</fpage>–<lpage>118</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Roberts1">
        <label>21</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Roberts</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Cooke</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Tran</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>WY</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Antigen-specific cytolysis by neutrophils and NK cells expressing chimeric immune receptors bearing zeta or gamma signaling domains</article-title>. <source>J Immunol</source> <volume>161</volume>: <fpage>375</fpage>–<lpage>384</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Haynes1">
        <label>22</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haynes</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Snook</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Trapani</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Cerruti</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jane</surname><given-names>SM</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Redirecting mouse CTL against colon carcinoma: superior signaling efficacy of single-chain variable domain chimeras containing TCRzeta vs Fc epsilon RI-gamma</article-title>. <source>J Immunol</source> <volume>166</volume>: <fpage>182</fpage>–<lpage>187</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Osman1">
        <label>23</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Osman</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lucas</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Reif</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Cantrell</surname><given-names>DA</given-names></name> (<year>1996</year>) <article-title>The protein interactions of the immunoglobulin receptor family tyrosine-based activation motifs present in the T cell receptor zeta subunits and the CD3 gamma, delta and epsilon chains</article-title>. <source>Eur J Immunol</source> <volume>26</volume>: <fpage>1063</fpage>–<lpage>1068</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Kersh1">
        <label>24</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kersh</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Shaw</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>PM</given-names></name> (<year>1998</year>) <article-title>Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation</article-title>. <source>Science</source> <volume>281</volume>: <fpage>572</fpage>–<lpage>575</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Paddock1">
        <label>25</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Paddock</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lytle</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Peterson</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Holyst</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Newman</surname><given-names>PJ</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Residues within a lipidassociated segment of the PECAM-1 cytoplasmic domain are susceptible to inducible, sequential phosphorylation</article-title>. <source>Blood</source> <volume>117</volume>: <fpage>6012</fpage>–<lpage>6023</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Xu1">
        <label>26</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gagnon</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Call</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Schnell</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Schwieters</surname><given-names>CD</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Regulation of T cell receptor activation by dynamic membrane binding of the CD3epsilon cytoplasmic tyrosine-based motif</article-title>. <source>Cell</source> <volume>135</volume>: <fpage>702</fpage>–<lpage>713</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Aivazian1">
        <label>27</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aivazian</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Stern</surname><given-names>LJ</given-names></name> (<year>2000</year>) <article-title>Phosphorylation of T cell receptor zeta is regulated by a lipid dependent folding transition</article-title>. <source>Nat Struct Biol</source> <volume>7</volume>: <fpage>1023</fpage>–<lpage>1026</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Zhang1">
        <label>28</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Cordoba</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Dushek</surname><given-names>O</given-names></name>, <name name-style="western"><surname>van der Merwe</surname><given-names>PA</given-names></name> (<year>2011</year>) <article-title>Basic residues in the T-cell receptor zeta cytoplasmic domain mediate membrane association and modulate signaling</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>108</volume>: <fpage>19323</fpage>–<lpage>19328</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Rotin1">
        <label>29</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rotin</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Margolis</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Mohammadi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Daly</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Daum</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>1992</year>) <article-title>SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gamma</article-title>. <source>EMBO J</source> <volume>11</volume>: <fpage>559</fpage>–<lpage>567</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Faeder2">
        <label>30</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Faeder</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Hlavacek</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Reischl</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Blinov</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Metzger</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Investigation of early events in Fc epsilon RI-mediated signaling using a detailed mathematical model</article-title>. <source>J Immunol</source> <volume>170</volume>: <fpage>3769</fpage>–<lpage>3781</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Kleiman1">
        <label>31</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kleiman</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Maiwald</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Conzelmann</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lauffenburger</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Sorger</surname><given-names>PK</given-names></name> (<year>2011</year>) <article-title>Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding</article-title>. <source>Mol Cell</source> <volume>43</volume>: <fpage>723</fpage>–<lpage>737</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-AltanBonnet1">
        <label>32</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Altan-Bonnet</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Germain</surname><given-names>RN</given-names></name> (<year>2005</year>) <article-title>Modeling T cell antigen discrimination based on feedback control of digital ERK responses</article-title>. <source>PLoS Biol</source> <volume>3</volume>: <fpage>e356</fpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Das1">
        <label>33</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Das</surname><given-names>J</given-names></name>, <name name-style="western"><surname>HoM, Zikherman</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Govern</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Digital signaling and hysteresis characterize ras activation in lymphoid cells</article-title>. <source>Cell</source> <volume>136</volume>: <fpage>337</fpage>–<lpage>351</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Fuss1">
        <label>34</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fuss</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Dubitzky</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Downes</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Kurth</surname><given-names>MJ</given-names></name> (<year>2008</year>) <article-title>SRC family kinases and receptors: analysis of three activation mechanisms by dynamic systems modeling</article-title>. <source>Biophys J</source> <volume>94</volume>: <fpage>1995</fpage>–<lpage>2006</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Dushek1">
        <label>35</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dushek</surname><given-names>O</given-names></name> (<year>2011</year>) <article-title>Elementary steps in T cell receptor triggering</article-title>. <source>Front Immunol</source> <volume>2</volume>: <fpage>91</fpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Dushek2">
        <label>36</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dushek</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Aleksic</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wheeler</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Cordoba</surname><given-names>SP</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation</article-title>. <source>Sci Signal</source> <volume>4</volume>: <fpage>ra39</fpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Salazar1">
        <label>37</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Salazar</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Höfer</surname><given-names>T</given-names></name> (<year>2009</year>) <article-title>Multisite protein phosphorylation–from molecular mechanisms to kinetic models</article-title>. <source>FEBS J</source> <volume>276</volume>: <fpage>3177</fpage>–<lpage>3198</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Dushek3">
        <label>38</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dushek</surname><given-names>O</given-names></name>, <name name-style="western"><surname>van der Merwe</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Shahrezaei</surname><given-names>V</given-names></name> (<year>2011</year>) <article-title>Ultrasensitivity in multisite phosphorylation of membrane-anchored proteins</article-title>. <source>Biophys J</source> <volume>100</volume>: <fpage>1189</fpage>–<lpage>1197</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Thomson1">
        <label>39</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thomson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gunawardena</surname><given-names>J</given-names></name> (<year>2009</year>) <article-title>Unlimited multistability in multisite phosphorylation systems</article-title>. <source>Nature</source> <volume>460</volume>: <fpage>274</fpage>–<lpage>277</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Liu1">
        <label>40</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Bardwell</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Nie</surname><given-names>Q</given-names></name> (<year>2010</year>) <article-title>A combination of multisite phosphorylation and substrate sequestration produces switchlike responses</article-title>. <source>Biophys J</source> <volume>98</volume>: <fpage>1396</fpage>–<lpage>1407</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Wang1">
        <label>41</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Nie</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Enciso</surname><given-names>G</given-names></name> (<year>2010</year>) <article-title>Nonessential sites improve phosphorylation switch</article-title>. <source>Biophys J</source> <volume>99</volume>: <fpage>L41</fpage>–<lpage>L43</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Markevich1">
        <label>42</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Markevich</surname><given-names>NI</given-names></name>, <name name-style="western"><surname>Hoek</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Kholodenko</surname><given-names>BN</given-names></name> (<year>2004</year>) <article-title>Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades</article-title>. <source>J Cell Biol</source> <volume>164</volume>: <fpage>353</fpage>–<lpage>359</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Kim1">
        <label>43</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Jeon</surname><given-names>BH</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Im</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Araki</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>IGSF4 is a novel TCR ?-chain-interacting protein that enhances TCR-mediated signaling</article-title>. <source>J Exp Med</source> <volume>208</volume>: <fpage>2545</fpage>–<lpage>2560</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Dushek4">
        <label>44</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dushek</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Goyette</surname><given-names>J</given-names></name>, <name name-style="western"><surname>van der Merwe</surname><given-names>PA</given-names></name> (<year>2012</year>) <article-title>Non-catalytic tyrosine-phosphorylated receptors</article-title>. <source>Immunol Rev</source> <volume>250</volume>: <fpage>258</fpage>–<lpage>276</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Barua1">
        <label>45</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barua</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Faeder</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Haugh</surname><given-names>JM</given-names></name> (<year>2008</year>) <article-title>Computational models of tandem SRC homology 2 domain interactions and application to phosphoinositide 3-kinase</article-title>. <source>J Biol Chem</source> <volume>283</volume>: <fpage>7338</fpage>–<lpage>7345</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Lipniacki1">
        <label>46</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lipniacki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hat</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Faeder</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Hlavacek</surname><given-names>WS</given-names></name> (<year>2008</year>) <article-title>Stochastic effects and bistability in T cell receptor signaling</article-title>. <source>J Theor Biol</source> <volume>254</volume>: <fpage>110</fpage>–<lpage>122</lpage>.</mixed-citation>
      </ref>
      <ref id="pcbi.1003004-Nag1">
        <label>47</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nag</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Monine</surname><given-names>MI</given-names></name>, <name name-style="western"><surname>Faeder</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Goldstein</surname><given-names>B</given-names></name> (<year>2009</year>) <article-title>Aggregation of membrane proteins by cytosolic cross-linkers: theory and simulation of the LAT-Grb2-SOS1 system</article-title>. <source>Biophys J</source> <volume>96</volume>: <fpage>2604</fpage>–<lpage>2623</lpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>